MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.antiviral.2023.105676

Медицинская библиотека · Antiviral research · 2023

Ceragenins exhibit antiviral activity against SARS-CoV-2 by increasing the expression and release of type I interferons upon activation of the host's immune response.

Suprewicz Łukasz, Szczepański Artur, Lenart Marzena, Piktel Ewelina, Fiedoruk Krzysztof, Barreto-Duran Emilia, Kula-Pacurar Anna, Savage Paul B, Milewska Aleksandra, Bucki Robert, Pyrć Krzysztof

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) heavily burdened the entire world socially and economically. Despite a generation of vaccines and therapeutics to confront infection, it remains a threat. Most available antivirals target viral proteins and block their activity or function. While such an approach is considered effective and safe, finding treatments for specific viruses of concern leaves us unprepared for developed resistance and future viral pandemics of unknown origin. Here, we propose ceragenins (CSAs), synthetic amphipathic molecules designed to mimic the properties of cationic antimicrobial peptides (cAMPs), as potential broad-spectrum antivirals. We show that selected CSAs exhibit antiviral activity against SARS-CoV-2 and low-pathogenic human coronaviruses 229E, OC43, and NL63. The mechanism of action of CSAs against coronaviruses is mainly attributed to the stimulation of antiviral cytokines, such as type I interferons or IL-6. Our study provides insight into a novel immunomodulatory strategy that might play an essential role during the current pandemic and future outbreaks.

Для цитирования: Suprewicz Łukasz, Szczepański Artur, Lenart Marzena, Piktel Ewelina, Fiedoruk Krzysztof, Barreto-Duran Emilia, Kula-Pacurar Anna, Savage Paul B, Milewska Aleksandra, Bucki Robert, Pyrć Krzysztof. Ceragenins exhibit antiviral activity against SARS-CoV-2 by increasing the expression and release of type I interferons upon activation of the host's immune response.. Antiviral research. 2023. DOI: 10.1016/j.antiviral.2023.105676.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.